These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23996617)

  • 1. Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy.
    Huang MY; Tsai HL; Lin CH; Huang CW; Ma CJ; Huang CM; Chai CY; Wang JY
    J Surg Oncol; 2013 Dec; 108(7):457-64. PubMed ID: 23996617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1.
    Gao R; Price DK; Sissung T; Reed E; Figg WD
    Mol Cancer Ther; 2008 May; 7(5):1246-50. PubMed ID: 18483312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.
    Yin M; Yan J; Martinez-Balibrea E; Graziano F; Lenz HJ; Kim HJ; Robert J; Im SA; Wang WS; Etienne-Grimaldi MC; Wei Q
    Clin Cancer Res; 2011 Mar; 17(6):1632-40. PubMed ID: 21278243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERCC1 codon 118 C→T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma.
    Chang PM; Tzeng CH; Chen PM; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Wang WS
    Cancer Sci; 2009 Feb; 100(2):278-83. PubMed ID: 19068092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
    Zhang H; Ge J; Hong H; Bi L; Sun Z
    World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinoma.
    Lai JI; Tzeng CH; Chen PM; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Wang WS
    Cancer Sci; 2009 Jul; 100(7):1261-6. PubMed ID: 19432884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Folfox6 as Adjuvant Chemotherapy in Vietnamese Patients With Colorectal Cancer.
    Nguyen TQ; Bui TO; Tran PT; Tran VT; Nguyen VH; Chu QH; Bui TAT; Le NQ; Le VQ; Dao VT
    Cancer Control; 2019; 26(1):1073274819864111. PubMed ID: 31317770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the impact of MiR-92a-3p on FOLFOX chemoresistance biomarker genes in colon cancer cell lines.
    Escalante PI; Quiñones LA; Contreras HR
    Front Pharmacol; 2024; 15():1376638. PubMed ID: 38659583
    [No Abstract]   [Full Text] [Related]  

  • 9. KIAA1549 promotes the development and chemoresistance of colorectal cancer by upregulating ERCC2.
    Ye F; Xie Y; Lin M; Liu Y; Fang Y; Chen K; Zhang Y; Ding Y
    Mol Cell Biochem; 2024 Mar; 479(3):629-642. PubMed ID: 37140813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desulfovibrio desulfuricans and its derived metabolites confer resistance to FOLFOX through METTL3.
    Li G; Liu H; Yu Y; Wang Q; Yang C; Yan Y; Wang F; Mao Y
    EBioMedicine; 2024 Apr; 102():105041. PubMed ID: 38484555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of ERCC2 gene in head and neck cancer is associated with aggressive tumors: a systematic review and case-control study.
    Zafeer M; Mahjabeen I; Kayani MA
    Int J Biol Markers; 2016 Feb; 31(1):e17-25. PubMed ID: 26659720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer.
    Kim DH; Lee H; Kim DH; Chae SW; Sohn JH; Kim K; Do SI
    Oncol Lett; 2017 Oct; 14(4):4995-5003. PubMed ID: 28943968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer.
    Vargas T; Moreno-Rubio J; Herranz J; Cejas P; Molina S; González-Vallinas M; Ramos R; Burgos E; Aguayo C; Custodio AB; Reglero G; Feliu J; Ramírez de Molina A
    Mol Oncol; 2014 Dec; 8(8):1469-81. PubMed ID: 25001263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid Molecular and Functional Micro-CT Imaging Reveals Increased Myocardial Apoptosis Preceding Cardiac Failure in Progeroid Ercc1 Mice.
    van Thiel BS; de Boer M; Ridwan Y; de Kleijnen MGJ; van Vliet N; van der Linden J; de Beer I; van Heijningen PM; Vermeij WP; Hoeijmakers JHJ; Danser AHJ; Kanaar R; Duncker DJ; van der Pluijm I; Essers J
    Mol Imaging Biol; 2024 Aug; 26(4):628-637. PubMed ID: 38498063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer.
    Chuang JP; Tsai HL; Chen PJ; Chang TK; Su WC; Yeh YS; Huang CW; Wang JY
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin and its analogs as prospective agents for the treatment of colorectal cancer.
    Massai L; Cirri D; Marzo T; Messori L
    Cancer Drug Resist; 2022; 5(1):1-14. PubMed ID: 35582525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased ATM Function Causes Delayed DNA Repair and Apoptosis in Common Variable Immunodeficiency Disorders.
    Hargreaves CE; Salatino S; Sasson SC; Charlesworth JEG; Bateman E; Patel AM; Anzilotti C; Broxholme J; Knight JC; Patel SY
    J Clin Immunol; 2021 Aug; 41(6):1315-1330. PubMed ID: 34009545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excision repair cross-complementing group 2 upregulation is a potential predictive biomarker for oral squamous cell carcinoma recurrence.
    Wang YY; Fang PT; Su CW; Chen YK; Huang JJ; Huang MY; Yuan SF
    Oncol Lett; 2021 Jun; 21(6):450. PubMed ID: 33868488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERCC overexpression associated with a poor response of cT4b colorectal cancer with FOLFOX-based neoadjuvant concurrent chemoradiation.
    Huang MY; Lee HH; Huang CW; Huang CM; Ma CJ; Yin TC; Tsai HL; Chai CY; Chen YT; Wang JY
    Oncol Lett; 2020 Nov; 20(5):212. PubMed ID: 32963618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer.
    Luo SS; Liao XW; Zhu XD
    Biomed Res Int; 2018; 2018():6204684. PubMed ID: 30417012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.